Skip to main content

Table 2 Laboratory parameters of the two groups

From: Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon

 

CSFP group (n = 89)

Control group (n = 167)

p value

White blood cell, 103/mm3

6.8 ± 1.2

6.4 ± 1.0

0.006

Neutrophils, 103/mm3

3.50 ± 0.32

3.46 ± 0.45

0.407

Lymphocytes, 103/mm3

2.01 ± 0.16

2.03 ± 0.28

0.543

Monocyte, 103/mm3

0.5 ± 0.1

0.4 ± 0.1

0.105

Eosinophils, 103/mm3

0.2 ± 0.1

0.1 ± 0.1

0.135

Haemoglobin, g/l

146.7 ± 9.7

145.8 ± 9.1

0.503

Platelets, 103/mm3

235.7 ± 9.7

232.5 ± 13.2

0.031

Total cholesterol, mmol/l

4.6 ± 0.4

4.7 ± 0.5

0.120

Triglyceride, mmol/l

1.5 ± 0.2

1.4 ± 0.3

0.112

HDL-C, mmol/l

1.0 ± 0.1

1.1 ± 0.2

0.030

LDL-C, mmol/l

3.0 ± 0.2

2.9 ± 0.3

0.136

Fasting plasma glucose, mmol/l

5.1 ± 0.5

5.0 ± 0.6

0.034

Urea, mmol/l

5.3 ± 0.7

5.1 ± 0.6

0.121

Creatinine, umol/l

73.2 ± 9.3

71.3 ± 9.9

0.125

Uric acid, umol/l

322.1 ± 27.3

313.7 ± 52.1

0.091

Mean platelet volume, fl

10.3 ± 1.0

10.0 ± 1.0

0.105

Neutrophil to lymphocyte ratio

1.74 ± 0.09

1.71 ± 0.12

0.034

Platelet to lymphocyte ratio

117.7 ± 10.1

116.6 ± 17.2

0.513

SII

409.7 ± 17.7

396.7 ± 12.7

 < 0.001

  1. CSFP: Coronary slow flow phenomenon, HDL-C: high-density lipoprotein choleste-
  2. rol, LDL-C: low-density lipoprotein cholesterol, SII: systemic immune-inflammation
  3. index